Literature DB >> 16304120

Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong.

Gregory E Antonio1, Clara G C Ooi, Ka Tak Wong, Eva L H Tsui, Joyce S W Wong, Alan N L Sy, Joyce Y H Hui, Cho Yin Chan, Henry Y H Huang, Yip Fai Chan, Tai Pang Wong, Lilian L Y Leong, Jane C K Chan, Anil T Ahuja.   

Abstract

PURPOSE: To retrospectively analyze serial chest radiographs in all patients with severe acute respiratory syndrome (SARS) in Hong Kong for temporal changes and differences between patients who died and those who were discharged from the hospital and to compare radiographic and clinical parameters.
MATERIALS AND METHODS: This retrospective study had ethics review board endorsement, and the need for informed consent was waived. Selected serial chest radiographs obtained from the time of presentation until discharge or death in 1373 patients with laboratory-confirmed SARS were scored. Scoring was based on the area and location of lung opacification on radiographs obtained at each of five milestones (presentation, beginning of ribavirin therapy, beginning of corticosteroid therapy, time of most severe radiographic appearance of disease, and before discharge or death). Extents of lung opacification at these five milestones were compared between patients who died and those who survived (by using a repeated-measures analysis of variance model), and the temporal trend of the radiographic-clinical parameters was analyzed (by using Cochran-Armitage trend testing, Kendall tau correlation coefficients, and descriptive graphic analysis).
RESULTS: The final cohort consisted of 1373 patients (1212 of whom [485 male and 727 female patients; mean age, 38.4 years] survived and 161 of whom [84 male and 77 female patients; mean age, 63.0 years] died). Among survivors, older patients had more extensive radiographic changes than younger ones. However, among patients who died, older patients had less extensive radiographic opacification at the worst stage of disease and just before death than did younger patients. Despite a higher mortality risk for male patients, both sexes in the same outcome group had similar radiographic findings. For both outcome groups, the rate of radiographic progression was similar for the first 11 days but diverged afterwards. The extent of opacification increased by approximately one zone every 4-5 days for the initial 11 days. Radiographic scores correlated with the ratio of PaO2 to the fraction of inspired oxygen, lymphocyte count, lactate dehydrogenase level, and neutrophil count at each milestone and in terms of changes between milestones (P < .01 for all correlation coefficients, except for radiographic score and neutrophil count between the first two milestones).
CONCLUSION: The initial extent of radiographic opacification may be useful for prognostic prediction. Radiographic progression correlates well with that of important clinical and laboratory parameters and may be used as an objective prognostic indicator early in SARS. RSNA, 2005

Entities:  

Mesh:

Year:  2005        PMID: 16304120     DOI: 10.1148/radiol.2373041919

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

Review 1.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 2.  Molecular imaging of influenza and other emerging respiratory viral infections.

Authors:  Mike Bray; James Lawler; Jason Paragas; Peter B Jahrling; Daniel J Mollura
Journal:  J Infect Dis       Date:  2011-03-21       Impact factor: 5.226

3.  Chest imaging features of patients afflicted with Influenza A (H1N1) in a Malaysian tertiary referral centre.

Authors:  Si Bux; N Mohd Ramli; S Ahmad Sarji; A Kamarulzaman
Journal:  Biomed Imaging Interv J       Date:  2010-10-01

4.  A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis.

Authors:  Lvliang Lu; Wenyu Zhong; Ziwei Bian; Zhiming Li; Ke Zhang; Boxuan Liang; Yizhou Zhong; Manjiang Hu; Li Lin; Jun Liu; Xi Lin; Yuji Huang; Junying Jiang; Xingfen Yang; Xin Zhang; Zhenlie Huang
Journal:  J Infect       Date:  2020-07-04       Impact factor: 6.072

5.  RadioGraphics Update: Radiographic and CT Features of Viral Pneumonia.

Authors:  Hyun Jung Koo; Sang-Ho Choi; Heungsup Sung; Jooae Choe; Kyung-Hyun Do
Journal:  Radiographics       Date:  2020-06-05       Impact factor: 5.333

6.  Chest X-rays findings in COVID 19 patients at a University Teaching Hospital - A descriptive study.

Authors:  Misbah Durrani; Inam Ul Haq; Ume Kalsoom; Anum Yousaf
Journal:  Pak J Med Sci       Date:  2020-05       Impact factor: 1.088

7.  Implementation of a Deep Learning-Based Computer-Aided Detection System for the Interpretation of Chest Radiographs in Patients Suspected for COVID-19.

Authors:  Eui Jin Hwang; Hyungjin Kim; Soon Ho Yoon; Jin Mo Goo; Chang Min Park
Journal:  Korean J Radiol       Date:  2020-07-17       Impact factor: 3.500

8.  A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome.

Authors:  Yung-Liang Wan; Pei-Kwei Tsay; Yun-Chung Cheung; Ping-Cherng Chiang; Chun-Hua Wang; Ying-Huang Tsai; Han-Ping Kuo; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

9.  Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.

Authors:  Huanyuan Luo; Yuancheng Wang; Songqiao Liu; Ruoling Chen; Tao Chen; Yi Yang; Duolao Wang; Shenghong Ju
Journal:  Intern Emerg Med       Date:  2021-06-30       Impact factor: 5.472

10.  Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.

Authors:  Yuhui Wang; Chengjun Dong; Yue Hu; Chungao Li; Qianqian Ren; Xin Zhang; Heshui Shi; Min Zhou
Journal:  Radiology       Date:  2020-03-19       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.